Most people infected with current COVID strains feel sick for about 7 to 10 days, though mild symptoms can linger a bit longer. The dominant variants circulating now belong to the JN.1 lineage (including subvariants like LP.8.1 and XFG), with a newer lineage called BA.3.2 gaining ground in parts of Europe. Despite the shifting names, the overall illness timeline has stayed relatively consistent across Omicron-era variants.
Incubation: Exposure to First Symptoms
Current Omicron-descended variants have a median incubation period of 3 to 4 days, meaning most people start feeling sick roughly three or four days after exposure. That’s noticeably faster than earlier versions of the virus. The original strain averaged about 6.5 days, and Delta came in around 4.3 days. With today’s variants, five or more days is still possible, but the majority of people develop symptoms sooner.
How Long Acute Symptoms Last
For most adults with a normal immune system, the worst of it hits in the first 2 to 4 days of symptoms: fever, body aches, sore throat, congestion, fatigue. These peak symptoms tend to improve noticeably by day 5 or 6. Milder symptoms like a lingering cough, mild fatigue, or a scratchy throat can stretch out to day 10 or occasionally beyond.
Vaccination status and prior infections both play a role. People with some level of immunity, whether from vaccines or a previous bout of COVID, generally report shorter and milder illness compared to those encountering the virus with little prior protection. Older adults and people with chronic health conditions may experience a longer symptomatic window.
When You’re Contagious
You can spread COVID starting 1 to 2 days before your symptoms appear, which is part of what makes the virus so hard to contain. Contagiousness typically extends 8 to 10 days after symptoms begin, though the heaviest period of transmission is concentrated early: the day or two before symptoms start and the first few days of feeling sick. By the time you’re on the tail end of your illness, viral levels have usually dropped significantly.
Current CDC guidance says you can return to normal activities once your symptoms have been improving for at least 24 hours and any fever has been gone for a full day without fever-reducing medication. After that, the CDC recommends taking extra precautions for the next 5 days, including wearing a well-fitting mask around others, improving ventilation, and maintaining distance when possible.
COVID Rebound
Some people feel better for a few days and then experience a return of symptoms. This is called COVID rebound, and it typically happens 3 to 7 days after the initial recovery or after testing negative. Rebound can occur whether or not you took antiviral treatment, though it has been frequently reported alongside antiviral use.
The good news is that rebound symptoms are generally mild and resolve within a few days. You may test positive again during a rebound, which means you’re potentially contagious during that window as well. If rebound adds another 3 to 5 days of symptoms on top of your initial illness, the total time feeling unwell could stretch to roughly two weeks.
When Symptoms Last Weeks or Months
Most people recover fully within two weeks, but a significant minority develop symptoms that persist well beyond the acute illness. This is commonly called long COVID, generally defined as symptoms lasting four weeks or more after infection. A large analysis of 35 studies across 19 countries, covering about 159,000 participants, found that roughly 23% of people infected during the Omicron era reported long COVID symptoms. That’s lower than the 35.5% seen with pre-Omicron variants, but still substantial.
The most common lingering symptoms include fatigue, brain fog, shortness of breath, and difficulty concentrating. In about 30% of long COVID cases, symptoms persisted beyond six months. The risk appears higher for people who had a more severe initial illness, those who were unvaccinated, and women, though researchers are still working to understand why some people recover quickly while others don’t.
What the Newer BA.3.2 Variant Might Mean
BA.3.2, a genetically distinct lineage from the JN.1 family, has been detected at prevalences of 10% to 40% in several European countries. It hasn’t become dominant in the United States yet, but it’s on surveillance radar. Lab studies show that the current LP.8.1-adapted vaccine produces the lowest antibody response against BA.3.2 compared to seven other tested variants, which raises questions about how well existing immunity will hold up if this lineage spreads further.
There’s no evidence yet that BA.3.2 causes a longer or more severe illness. New variants historically shift in transmissibility and immune evasion more than they change the basic timeline of sickness. Still, reduced vaccine effectiveness could mean more symptomatic infections overall, even in people who are up to date on their shots.